We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance: Pharmacogenomics Offer Top Early-Stage Data
Guidance: Pharmacogenomics Offer Top Early-Stage Data
March 2, 2011
Conducting pharmacogenomic studies can help sponsors obtain better early-stage data for new drugs, according to new FDA draft guidance.